Solid Multicomponent Systems: Continuous Manufacturing Approaches for Improved Drug Product Quality
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (20 October 2021) | Viewed by 38013
Special Issue Editors
Interests: pharmaceutics; process engineering; modelling; separation; nanomaterials
Special Issue Information
Dear Colleagues,
In recent years, academia and the pharmaceutical industry have been increasingly interested in the manipulation of the solid-state of APIs to improve physicochemical properties. There are various approaches for solid-state pharmaceutical development, such as the formation of salts, amorphous formulations, solvates, cocrystals, liquid crystals, and nano-cocrystals. An important goal of solid-state pharmaceutical development is to mitigate the solubility, stability, and manufacturability of the final drug form.
In the pharmaceutical industry, manufacturing processes have traditionally favored batch processing. However, In recent times, interest in continuous manufacturing has also increased, which provides significant advantages including shorter development times, production of higher-quality products, reduced cost, real-time monitoring, and better process control. Scalable and continuous processes such as continuous crystallizers, high-shear granulation, hot melt extrusion (HME), and spray drying have recently been used for various multicomponent continuous preparation. Despite extensive research in the field of multicomponent systems, the development of end-product formulations has generally been understudied.
There is a need to understand the scientifically challenging questions relevant to this field, including the following:
Is it possible to enhance the capabilities in the context of computational techniques to rationalize multicomponent system experimental results?
How can we gain more insight into underlying mechanisms during solid-state pharmaceutical development to ensure multicomponent systems product quality attributes?
Is it possible to design and optimize processes to manufacture engineered multicomponent systems?
Is it possible to develop efficient production methods on a large scale for solid-state multicomponent systems?
By answering these questions, we can efficiently overcome obstacles facing the design of scalable and continuous processes for multicomponent systems that result in more uniform final products. Therefore, this Special Issue will highlight the current state and future perspectives on developing a multicomponent system drug product from screening to process design. We invite contributions on all aspects of the topic from both industry and academia.
Dr. Saeed Shirazian
Dr. Rahamatullah Shaikh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- continuous pharmaceutical manufacturing
- multicomponent systems
- process analytical technology (PAT)
- formulation
- large-scale production
- process design and optimization
- computational methods
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.